ACHE and early-onset autosomal dominant Alzheimer disease: Additionally, their potential in combating Alzheimer’s disease was estimated by evaluating their inhibitory activity against cholinesterase enzymes, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE).